These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 4303132)

  • 1. Dysfibrinogenemia in a patient with primary hepatoma. First observation of an acquired abnormality of fibrin monomer aggregation.
    von Felten A; Straub PW; Frick PG
    N Engl J Med; 1969 Feb; 280(8):405-9. PubMed ID: 4303132
    [No Abstract]   [Full Text] [Related]  

  • 2. Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule.
    Gralnick HR; Givelber H; Abrams E
    N Engl J Med; 1978 Aug; 299(5):221-6. PubMed ID: 207986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancer.
    Pengo V; Levi Minzi S; Dal Bo Zanon R; Cappellato G; Farinati F; Girolami A
    J Med; 1984; 15(2):149-60. PubMed ID: 6096471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfibrinogenaemia associated with primary hepatoma.
    Verhaeghe R; van Damme B; Molla A; Vermylen J
    Scand J Haematol; 1972; 9(5):451-8. PubMed ID: 4342317
    [No Abstract]   [Full Text] [Related]  

  • 5. [The rapid determination of fibrin and fibrinogen split products with a bedside thrombin coagulase time test in obstetric coagulopathies (author's transl)].
    Kastendieck E; Barthels M
    Geburtshilfe Frauenheilkd; 1974 Sep; 34(9):758-62. PubMed ID: 4437565
    [No Abstract]   [Full Text] [Related]  

  • 6. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
    Al-Mondhiry H; Galanakis D
    J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperfibrinogenemia and prolonged clotting times in a Turner syndrome patient with hepatocellular carcinoma.
    Zhao X; Wang Z; Cao L; Zhang W; Bai X; Dong N; Yu Z; Ruan C
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):398-405. PubMed ID: 20410814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential diagnosis between primary and secondary hyperfibrinolysis].
    Heene DL
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):186-94. PubMed ID: 4098772
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new case of dysfibrinogenemia].
    Krause W; Heene D; Lasch HG
    Klin Wochenschr; 1971 Jul; 49(14):806-8. PubMed ID: 5563018
    [No Abstract]   [Full Text] [Related]  

  • 10. Acquired dysfibrinogenemia in a hemophiliac with hepatoma: resolution of fibrinogen dysfunction following chemotherapy.
    Ballard JO; Kelly GA; Kukrika MD; Sanders JC; Eyster ME
    Cancer; 1981 Aug; 48(3):686-90. PubMed ID: 6265056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical hemorrhagic syndrome. Elaboration of a practical procedure of investigation and treatment in the absence of a specialized laboratory].
    Otteni JC; Boyer C; Girardel JM; Gauthier-Lafaye JP
    Anesth Analg (Paris); 1969; 26(1):89-106. PubMed ID: 5793321
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of coagulation screening test results in two cases having dysfibrinogen].
    Terasawa F; Sasaki Y; Ishikawa S; Nakagoshi R; Furihata K; Katsuyama T; Okumura N
    Rinsho Byori; 1996 Aug; 44(8):791-6. PubMed ID: 8816067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen Amsterdam, another hereditary abnormality of fibrinogen.
    Janssen CL; Vreeken J
    Br J Haematol; 1971 Mar; 20(3):287-98. PubMed ID: 4101579
    [No Abstract]   [Full Text] [Related]  

  • 14. [Difficulties in the biologic diagnosis of the disseminated intravascular coagulation syndrome. Apropos of 5 cases].
    Streiff F; Peters A; Alexandre P
    Nouv Rev Fr Hematol; 1968; 8(1):104-10. PubMed ID: 4232753
    [No Abstract]   [Full Text] [Related]  

  • 15. [Abnormalities of fibrin formation in benign viral hepatitis (author's transl)].
    Thabaut A; Laverdant C; Durosoir JL; Cristau P; Essioux J; Molinié C
    Ann Med Interne (Paris); 1979; 130(1):35-8. PubMed ID: 434713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficiency and limits of fibrinolytic system function tests].
    van de Loo J
    Internist (Berl); 1973 Apr; 14(4):170-4. PubMed ID: 4577210
    [No Abstract]   [Full Text] [Related]  

  • 17. Assays for fibrinogen and its derivatives.
    Shaw ST
    CRC Crit Rev Clin Lab Sci; 1977 Oct; 8(2):145-92. PubMed ID: 334467
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acquired dysfibrinogenemia and hepatic disorders. Apropos of 30 cases].
    Aiach M; Rogé J; Busy MF; Durand H; Guéroult N; Chanrion C; Leclerc M; Justin-Besançon L
    Sem Hop; 1973 Jan; 49(3):183-97. PubMed ID: 4349616
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrinogen and the fibrinogenopathies.
    Morse EE
    Ann Clin Lab Sci (1971); 1971; 1(2):155-61. PubMed ID: 4949447
    [No Abstract]   [Full Text] [Related]  

  • 20. [Familial dysfibrinogenemia with abnormal nonomer aggregation. Paris III fibrinogen].
    Soria J; Soria C
    Pathol Biol (Paris); 1974 Nov; 22 suppl():72-9. PubMed ID: 4620099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.